Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum

Indian Heart Journal

Volumn 69, Issue , 2017, Pages S34-S45

  Sabin, Padmajan ^a   Koshy, Alummoottil George ^a   Gupta, Prabha Nini ^a   Sanjai, Pattu Valappil ^a   Sivaprasad, Kunjukrishanpilla ^a   Velappan, Praveen ^a   Vellikat Velayudhan, Radhakrishnan ^a  

^a Medical College Hospital Thiruvananthapuram   (India)

Author keywords

No reflow; Predictors; Primary angioplasty

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ANGIOPLASTY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NO REFLOW PHENOMENON; POSTOPERATIVE COMPLICATION; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; FOLLOW UP; HOSPITAL MORTALITY; INCIDENCE; MIDDLE AGED; PEROPERATIVE COMPLICATION; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TEACHING HOSPITAL; TIME FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TRENDS;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; NO-REFLOW PHENOMENON; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 85008627613     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ihj.2016.12.012     Document Type: Article

References (76)

1. 1 Weawer, W.D., Simes, R.J., Betriu, A., et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review. JAMA 278 (1997), 2093–2098.
2. 2 Keeley, E.C., Boura, J.A., Grines, C.L., Primary angioplasty versus thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 361 (2003), 13–20.
3. 3 Ito, H., Okamura, A., Iwakura, K., et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 93 (1996), 1993–1999.
4. 4 Reffelmann, T., Kloner, R.A., The no-reflow phenomenon: basic science and clinical correlates. Heart 87 (2002), 162–168.
5. 5 Bulluck, H., Sirker, Loke, Y.K., Garcia-Dorado, D., Hausenloy, D.J., Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevationmyocardial infarction patients: an updated meta-analysis of randomizedcontrolled trials. Int J Cardiol 201:202 (2016), 228–237.
6. 6 Mazhar, J., Mashicharana, M., Farshid, A., Predictors and outcome of no-reflow post primary percutaneouscoronary intervention for ST elevation myocardial infarction. IJC Heart Vasc 10 (2016), 8–12.
7. 7 Kloner, R.A., Ganote, C.E., Jennings, R.B., The ‘no-reflow’ phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54 (1974), 1496–1508.
8. 8 Ito, H., Tomooka, T., Sakai, N., et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85 (1992), 1699–1705.
9. 9 Ito, H., Maruyama, A., Iwakura, K., et al. Clinical implications of the ‘no reflow’ phenomenon: a predictor of complications and left ventricular remodelling in reperfused anterior wall myocardial infarction. Circulation 93 (1996), 223–228.
10. 10 Krug, A., de Rochemont, W.M., Korb, G., Blood supply of the myocardium after temporary coronary occlusion. Circ Res 19 (1996), 57–62.
11. 11 Schofer, J., Montz, R., Mathey, D., Scintigraphic evidence of the ‘no-reflow’ phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 5 (1985), 593–598.
12. 12 Ito, H., Iwakura, K., Assessing the relation between coronary reflow and myocardial reflow. Am J Cardiol 81:Suppl. 12A (1998), 8G–12G.
13. 13 Piana, R.N., Paik, G.Y., Moscucci, M., et al. Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention. Circulation 89:Suppl. 12A (1994), 2514–2518 8G–12G.
14. 14 Abbo, K.M., Dooris, M., Glazier, S., Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 75 (1995), 778–782.
15. 15 Majno, G., Ames, A., Chaing, J., Wright, R.L., No reflow after cerebral ischemia. Lancet 2 (1967), 569–570.
16. 16 Willms-Kretschmer, K., Majno, G., Ischemia of the skin: electron microscopic study of vascular injury. Am J Pathol 54 (1969), 327–343.
17. 17 Bates, E.R., Krell, M.J., Dean, E.N., O'Neill, W.W., Vogel, R.A., Demonstration of ‘no reflow’ phenomenon by digital coronary arteriography. Am J Cardiol 57 (1986), 177–178.
18. 18 Pomerantz, R.M., Kuntz, R.E., Diver, D.J., Safian, R.D., Baim, D.S., Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn 24 (1991), 283–285.
19. 19 Feld, H., Lichstien, E., Schachter, J., Shani, J., Early and late angiographic findings of the ‘no-reflow’ phenomenon following direct angioplasty as the primary treatment for acute myocardial infarction. Am Heart J 123 (1992), 782–784.
20. 20 Reimer, K.A., Lowe, J.E., Rasmussen, M.M., et al. The wavefront phenomenon of ischemic cell death, 1: myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56 (1977), 786–794.
21. 21 Ambrosio, G., Weisman, H.F., Mannisi, J.A., et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80 (1989), 1846–1861.
22. 22 Kloner, R.A., Does reperfusion injury exist in humans?. J Am Coll Cardiol 21 (1993), 537–545.
23. 23 Topol, E.J., Yadav, J.S., Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000), 570–580.
24. 24 Cuypers, J., Matakas, F., The effect of postischemic hyperemia on intracranial pressure and the no-reflow phenomenon. Acta Neuropathol (Berl) 29 (1974), 73–84.
25. 25 Douglas, B., Weinberg, H., Song, Y., et al. Beneficial effects of ibuprofen on experimental microvascular free flaps: pharmacologic alteration of the no-reflow phenomenon. Plast Reconstr Surg 79 (1987), 366–371.
26. 26 Hataya, Y., Matsuo, K., Ishigaki, M., et al. Retrograde intra-arterial infusion of prostaglandin E1 and heparin for the no-reflow phenomenon after oromandibular reconstruction with a free fibular flap. Ann Plast Surg 42 (1999), 92–95.
27. 27 Calhoun, K.H., Tan, L., Seikaly, H., An integrated theory of the no-reflow phenomenon and the beneficial effect of vascular washout on no-reflow. Laryngoscope 109 (1999), 528–535.
28. 28 Engler, R.L., Schmid-Schönbein, G.W., Pavelec, R.S., Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 111 (1983), 98–111.
29. 29 Barroso-Aranda, J., Schmid-Schönbein, G.W., Zweifach, B.W., et al. Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res 63 (1988), 437–447.
30. 30 Arteaga, C., Revel, D., Zhao, S., et al. ‘Myocardial low’ assessed by Dy-DTPA-BMA-enhanced first-pass MR imaging in a dog model. J MagnReson Imaging 9 (1999), 679–684.
31. 31 Kloner, R.A., No-reflow revisited. J Am Coll Cardiol 14 (1989), 1814–1815.
32. 32 Kitazume, H., Iwama, T., Kubo, H., et al. No-reflow phenomenon during percutaneous transluminal coronary angioplasty. Am Heart J 116 (1988), 211–215.
33. 33 Safian, R.D., Niazi, K.A., Strzelecki, M., et al. Detailed angiographic analysis of high-speed mechanical rotational atherectomy in human coronary arteries. Circulation 88 (1993), 961–968.
34. 34 Kaplan, B.M., Benzuly, K.H., Kinn, J.W., et al. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn 39 (1996), 113–118.
35. 35 Diez, J.G., Fish, R.D., Croitoru, M., et al. The slow-flow, no-flow phenomena during rotational atherectomy: does abciximab help. Circulation 98:Suppl. I (1998), I–558.
36. 36 Sharma, S.K., Dangas, G., Mehran, R., et al. Risk factors for the development of slow flow during rotational coronary atherectomy. Am J Cardiol 80 (1997), 219–222.
37. 37 Cohen, B.M., Weber, V.J., Blum, R.R., et al. Cocktail attenuation of rotational ablation flow effects (CARAFE) Study: pilot. Cathet Cardiovasc Diagn(Suppl. 3), 1996, 69–72.
38. 38 Abbo, K.M., Dooris, M., Glazier, S., et al. No-reflow after percutaneous coronary intervention: clinical and angiographic characteristics, treatment and outcome. Am J Cardiol 75 (1995), 778–782.
39. 39 Braunwald, E., Kloner, R.A., Myocardial reperfusion: a double-edged sword?. J Clin Invest 76 (1985), 1713–1719.
40. 40 Bowles, M., Palko, W., Beaver, C., et al. Clinical and postmortem outcome of no-reflow phenomenon in a patient treated with rotational atherectomy. South Med J 89 (1996), 820–823.
41. 41 Gibson, C.M., Ryan, K.A., Murphy, S.A., et al. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. J Am Coll Cardiol 34 (1999), 974–982.
42. 42 Marzilli, M., Gliozheni, E., Marraccini, P., et al. Primary coronary angioplasty in acute myocardial infarction: clinical correlates of the no reflow phenomenon. Int J Cardiol 65:Suppl. 1 (1998), s23–s28.
43. 43 Takahashi, T., Anzai, T., Yoshikawa, T., et al. Absence of preinfarction angina is associated with a risk of no-reflow phenomenon after primary coronary angioplasty for a first anterior wall acute myocardial infarction. Int J Cardiol 75 (2000), 253–260.
44. 44 Kloner, R.A., Shook, T., Przyklenk, K., et al. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning?. Circulation 92 (1995), 1064–1065.
45. 45 Aiello, E.A., Jabr, R.I., Cole, W.C., Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia: role of oxygen radical-induced no-reflow phenomenon. Circ Res 77 (1995), 153–162.
46. 46 Morishima, I., Sone, T., Mokuno, S., et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 130 (1995), 239–243.
47. 47 Morishima, I., Sone, T., Okumura, K., et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36 (2000), 1202–1209.
48. 48 Villanueva, F.S., et al. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implication in determining extent of myocardial salvage. Circulation 88 (1993), 2596–2606.
49. 49 Zijlstra, F., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328 (1993), 680–684.
50. 50 Simes, R.J., Topol, E.J., D.R, Holmes Junior, et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion.GUSTO-I Investigators. Circulation 91 (1995), 1923–1928.
51. 51 Akasaka, T., Yoshida, K., Kawamoto, T., et al. Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation 101 (2000), 2361–2367.
52. 52 Yamamoto, K., Ito, H., Iwakura, K., et al. Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction:insight into mechanisms of microvascular dysfunction. J Am Coll Cardiol 40 (2002), 1755–1760.
53. 53 Wu, K.C., Zerhouni, E.A., Judd, R.M., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97 (1998), 765–772.
54. 54 Taylor, A.J., et al. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 109 (2004), 2080–2085.
55. 55 Vlaar, P.J., Svilaas, T., van der Horst, I.C., et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371:9628 (2008), 1915–1920, 10.1016/S0140-6736(08)60833-8.
56. 56 Fröbert, O., Lagerqvist, B., Göran, K., et al. Thrombus aspiration during ST-Segment elevation myocardial infarction. N Engl J Med 369 (2013), 1587–1597, 10.1056/NEJMoa130878 [I year follow-up of the Taste trial].
57. 57 Jolly, S.S., Cairns, J.A., Yusuf, S., et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial. Lancet 387 (2016), 127–135, 10.1016/s0140-6736(15)00448-1.
58. 58 Kocher, A.A., Schuster, M.D., Sabolcs, M.J., et al. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis reduces remodelling and improves cardiac function. Nat Med 7 (2001), 430–436.
59. 59 Aksu, T., Guler, T.E., Colak, A., et al. Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study. BMC Cardiovasc Disord, 15(10), 2015, 10.1186/s12872-015-0004-6.
60. 60 Ross, A.M., Gibbons, R.J., Stone, G.W., Randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45 (2005), 1775–1780.
61. 61 Stone, G.W., Webb, J., Cox, D.A., et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction:a randomized controlled trial. JAMA 293 (2005), 1063–1072.
62. 62 Gick, M., Jander, N., Jander, H.P., et al. Randomized evaluation of the effects of fil¬ter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 112 (2005), 1462–1469.
63. 63 Marzilli, M., Orsini, E., Marraccini, P., Testa, R., Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 101 (2000), 2154–2159.
64. 64 Ito, H., Taniyama, Y., Iwakura, K., et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 33 (1999), 654–666.
65. 65 Ishii, H., Ichimiya, S., Kanashiro, M., Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 112 (2005), 1284–1288.
66. 66 Pasceri, V., Pristipino, C., Pelliccia, F., et al. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol 95 (2005), 1358–1361.
67. 67 Theroux, P., Myocardial cell protection:a challenging time for action and a challenging time for clinical research. Circulation 101 (2000), 2874–2876.
68. 68 Théroux, P., Chaitman, B.R., Danchin, N., et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Circulation 102 (2000), 3032–3038.
69. 69 Zeymer, U., Suryapranata, H., Monassier, J.P., et al. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myo¬cardial infarction. Characteristics of the pathological images of coronary artery thrombi according to the infarct-related coronary artery in acute myocardial infarction. Circ J 68 (2004), 308–314.
70. 70 Yip, H.K., Chen, M.C., Chang, H.W., et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-flow. Chest 122 (2002), 1322–1332.
71. 71 De Luca, G., Ernst, N., Zijlstra, F., et al. Preprocedural TIMI fl ow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 43 (2004), 1363–1367.
72. 72 Watanabe, T., Nanto, S., Uematsu, M., et al. Prediction of no-reflow phenomenon after successful percutaneous coronary intervention in patients with acute myocardial infarction: intravascular ultrasound findings. Circ J 67 (2003), 667–671.
73. 73 Tanaka, A., Kawarabayashi, T., Nishibori, Y., et al. No-refl ow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 105 (2002), 2148–2152.
74. 74 Katayama, T., Kubo, N., Takagi, Y., et al. Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction. Am J Cardiol 97 (2006), 301–304.
75. 75 Bae, J.H., Kwon, T.G., Hyun, D.W., Rihal, C.S., Lerman, A., Predictors of slow fl ow during primary percutaneous coronary intervention:an intravascular ultrasound virtual histology study. Heart 94 (2008), 1559–1564.
76. 76 Kirma, C., Izgi, A., Dundar, C., et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J 72 (2008), 716–721.